pix11

CMS Recognizes Valencia Technologies' eCoin® System Coding and Payment in 2024 Proposed Medicare Rule, Advancing Treatment for Urgency Urinary Incontinence

VALENCIA, Calif., July 17, 2023 /PRNewswire/ -- Valencia Technologies Corporation announced today that the Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS), ...
WGNO

Anthem Blue Cross and Blue Shield Announces Coverage for the eCoin System for Urinary Incontinence

VALENCIA, Calif., Jan. 9, 2024 /PRNewswire/ --Valencia Technologies Corporation announced today that Anthem Blue Cross and Blue Shield published a coverage policy for the eCoin ® System procedure ...
Mena FN

Valencia Technologies Announces First Commercial Implantation Of Ecoin® Leadless Tibial Neurostimulator For The Treatment Of Urge Urinary Incontinence'

VALENCIA, Calif. , June 6, 2022 /PRNewswire/ -- Valencia Technologies Corporation, a privately held company, today announced that it has completed the world's first commercial implantation of eCoin® ...
NBC4 Columbus

Valencia Technologies Retains PRIA Healthcare to Improve Patient Access to the eCoin for treatment of Urge Urinary Incontinence (UUI)

VALENCIA, Calif., May 10, 2022 /PRNewswire/ -- Valencia Technologies Corporation ("Valencia" or the "Company"), a privately held company, today announced it has retained PRIA Healthcare to assist in ...
Renal & Urology News

Implantable Tibial Neurostimulator Promising for Urge Urinary Incontinence

In a pilot study, the eCoin device yielded a dry rate of 30.33% at 36 weeks. A subcutaneously implanted tibial nerve stimulation device, eCoin, showed safety and efficacy for treating urgency urinary ...
Pharm Exec

Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO

Valencia will seek to leverage the investment as well as Surek’s leadership experience to drive commercialization of its flagship eCoin system to develop minimally invasive treatments for urinary ...